An upcoming merger agreement between Pfizer and Anacor, worth around $5.2 billion, could boost the marketing power of Anacor’s lead pipeline candidate,

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

New User Registration
Please indicate that you agree to the Terms of Service *
*Required field